coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Chorley Central PCN, Chorley · Health Inequalities Profile

    PCN U01901 · NHS Lancashire and South Cumbria Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    54,699

    Registered population

    58.5% aged 18–64

    23.2%

    Aged 65+

    ICB 20.0% · England 17.9%

    2.4%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    13.5%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~7,524

    Core20 residents (est.)

    Resident basis; registered basis ~7,669 · see page 3

    10,883

    Hypertension register

    +7.28% in 3 yrs · England +5.60%

    651

    SMI register

    47.7% of Chorley's

    1,496

    COPD register

    Reviews +5.02% in 3 yrs

    Forecast to 2030

    12,700

    Hypertension patients, 2030

    +1,817 on today

    70.5%

    QRISK ≥20% on statins, 2030

    +4.47pp over 3 yrs

    5.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    60.4%
    High-risk lipid and statin treatment lags England.

    Lipid therapy for QRISK ≥ 20% (60.4% vs England 63.6%) and diabetes statins (70.3% vs 73.2%) trail nationally, which may reflect unverified recall gaps.

    about 1,300
    Unreviewed asthma cohort alongside high child prescribing.

    Despite 69.7% annual review uptake (England 65.7%), about 1,300 asthma patients lack reviews while child prescribing is 2,037 per 1,000 (England 1,488).

    83.6%
    Hypertension control and SMI checks exceed England.

    SMI blood pressure checks rose +9.9 pp over three years to 83.6% (England 83.4%), while hypertension treatment to target reaches 71.6% (England 70.3%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 23.2% aged 65+, the PCN has an older population than England's 17.9%

    Chorley Central PCN has 54,699 registered patients with an older demographic: 23.2% (12,687) are aged 65+, compared to 20.2% in Chorley, 20.0% in NHS Lancashire and South Cumbria ICB, and 17.9% in England. Adults aged 18–64 account for 58.5% and children aged 0–17 for 18.3%. Census estimates show 97.7% White residents (Chorley 95.6%, ICB 87.8%, England 81.1%) and 2.4% ethnic minorities, reflecting resident areas rather than registrations. Older age profiles may increase frailty demand ahead of projected 1.8% list growth to 2030, which uses an unverified methodology.

    Age profile

    0–1718.3%
    18–6458.5%
    65+23.2%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White97.7%
    Asian1.4%
    Mixed0.5%
    Black0.3%
    Other0.1%

    Older people · falls rows are Chorley local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Chorley LA)1,6352,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Chorley LA)7431,0219552024/25
    Falls deaths, all ages, per 100,000 (Chorley LA)10.418.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 13.5% across the PCN and concentrated entirely within three practices

    The PCN Core20 cohort is 13.5% (Chorley 11.4%, England 21.0%, ICB 30.6%). Deprivation is concentrated in The Chorley Surgery (24.9%, est. 2,455 patients), Library House Surgery (21.9%, est. 3,625 patients) and Regent House Surgery (20.8%, est. 1,589 patients), whereas Coppull Medical Practice, Granville House Med Ctre and The Euxton Medical Centre record 0.0%. A reconciliation warning notes the weighted practice share of 14.0% exceeds the PCN rate by 0.52 percentage points. Focusing outreach on high-volume practices targets resources where deprivation is concentrated.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Chorley24.9% · 2,455 patients
    Library House21.9% · 3,625 patients
    Regent House20.8% · 1,589 patients
    Coppull Medical0.0% · 0 patients
    Granville House0.0% · 0 patients
    Euxton0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    651

    SMI register

    1.18% recorded prevalence

    385

    Learning disability register

    0.70% recorded prevalence

    16

    Care homes, 681 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Chorley, Census 2021

    The PCN records 651 severe mental illness patients (1.2% vs Chorley 1.1%, ICB 1.2%, England 1.0%) and 385 learning disability patients (0.7% vs 0.6% across comparators), representing 47.7% and 46.7% of borough registers. Catchment assets include 16 care homes with 681 beds. These inclusion registers and care home beds indicate substantial ongoing care coordination workload across the network.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.2%. Annual BP checks reached 83.6% (England 83.4%) and BMI recording 83.2% (England 82.1%). Smoking cessation offers fell 3.0 pp over three years (England +0.1 pp) to 94.0%, which could reflect unverified referral gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,883

    Hypertension register

    +7.28%

    Register growth, 3 yrs

    Chorley +6.44% · England +5.60%

    +4.33pp

    BP control, under 80

    ≤140/90 · +4.30pp aged 80+

    +1,817

    More patients by 2030

    Forecast 12,700 (22.70%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 19.7% (10,883 patients), above Chorley (17.5%), the ICB (17.2%) and England (15.2%), consistent with an older population (23.2% aged 65+). Prevalence changed +1.3 pp over three years (England +0.8 pp). Recent blood pressure monitoring reached 89.7% (England 90.0%), and patients treated to target reached 71.6% (England 70.3%). For patients aged 80 and over, control is 81.2%, in line with England (81.2%) but below Chorley (82.0%) and the ICB (81.8%). Lower control in patients aged 80 and over compared to local benchmarks indicates an opportunity to review titration protocols.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 60.4%, trailing England (63.6%) and the ICB (61.4%). Statin coverage in diabetes patients aged 40+ without cardiovascular disease is 70.3% (England 73.2%). Lower uptake may reflect unverified recall gaps that practice audits would test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026111,605£1.80£1.64£1.86£200,889
    Cardiovascular (all), 2025168,974£4.05£3.38£3.33£684,345

    In 2026, lipid-regulating drugs averaged £1.80 per item across 111,605 items (England £1.86, ICB £1.64). Across these items, the PCN spent £6,696 less than at England's unit cost, and £17,857 more than at NHS Lancashire and South Cumbria Integrated Care Board's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +4.49%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.09%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 8.2% (4,284 patients; England 6.6%). Annual reviews reached 69.7% (England 65.7%), leaving about 1,300 patients unreviewed. Paediatric asthma prescribing reached 2,037 items per 1,000 aged 5-19, above England (1,488) and the ICB (1,828). Second-hand smoke recording for ages 6-19 is 79.1% (Chorley 82.8%). COPD prevalence is 2.7% (1,496 patients; England 1.9%), with reviews at 81.5% (England 76.4%). Higher paediatric prescribing alongside unreviewed patients could reflect unverified disease control shortfalls that medication and recall audits would clarify.

    Cancer register and children's immunisation

    Cancer prevalence is 4.9% (2,700 patients; England 3.8%). In childhood immunisations, 24-month MMR dose 1 reaches 95.4% (England 88.3%). However, age-5 coverage falls below the 95.0% target: MMR dose 1 is 91.7% and dose 2 is 86.4% (below target by 8.6 pp), showing a 5.3 pp same-cohort drop. The 4-in-1 booster also trails at 86.4%. This could reflect unverified pre-school recall drop-off.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.6%

    England 91.0%

    6-in-1 complete primary course at 24 months95.4%

    England 92.2%

    MMR dose 1 at 24 months95.4%

    England 88.3%

    MMR dose 2 at age 586.4%

    England 82.8%

    4-in-1 pre-school booster at age 586.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of cancers with a known stage (4,642 of 8,863; known-stage share 74.6% of 11,883) were diagnosed at stage 1 or 2 (England 55.3%), falling 22.6 pp below the 75.0% national ambition by 2028 (ICB data, not PCN performance). Early-stage share fell 1.2 pp from 53.6% in 2013, needing about 2,010 extra early diagnoses annually. Early detection was 86.0% for breast, 44.2% for bowel, and 31.1% for lung. PCN three-year cancer prevalence grew +7.5% (England +9.0%), with The Chorley Surgery at +2.3% and Library House Surgery at +4.3%. ICB staging gaps highlight the importance of reviewing practice referral and coding processes.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data (provider performance, not PCN level), Lancashire Teaching Hospitals NHS Foundation Trust achieved 82.9% on the 28-day faster diagnosis standard (75.0% standard; ICB 78.4%, England 79.3%; Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust 82.8%, East Lancashire Hospitals NHS Trust 81.5%). The 62-day referral to treatment rate was 75.0%, falling 10.0 pp below the 85.0% standard (ICB 73.6%, England 71.2%; Wrightington, Wigan and Leigh 76.8%, East Lancashire 73.2%). Computed Tomography 6-week diagnostic waits reached 15.0% (England 9.9%). These provider-level delays reflect wider system pressure along diagnostic pathways.

    Pathways within standard (%)LancashireWrightington, Wigan and LeighEast LancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)82.9082.8081.5078.3979.32
    31-day treatment (96%)89.4389.0498.1193.6292.50
    62-day referral to treatment (85%)75.0476.7873.1673.6271.16
    Diagnostic waits over 6 weeks (%)LancashireWrightington, Wigan and LeighEast LancashireEngland
    MRI2.410.490.4321.40
    CT14.977.780.159.92
    Echocardiography13.8524.370.0028.48
    Colonoscopy0.006.100.9530.83
    Gastroscopy0.0012.541.1629.02
    All 15 DM01 tests26.6514.363.2523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). Provisional Community Services Dataset figures for June 2026 indicate that 56.9% of community contacts with Chorley borough residents (72,000 of 126,445 contacts) were with adults aged 65 and over (borough-level data, not PCN level). This activity reflects substantial community care utilisation among older residents across the wider borough.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, overall QOF achievement ranged from 88.5% at Library House Surgery to 100.0% at Coppull Medical Practice (England 92.5%). In the vaccination and immunisation domain, achievement spanned 56.7 pp, with 43.0% at The Chorley Surgery, 44.3% at Library House Surgery, and 99.7% at Coppull Medical Practice (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Euxton900.072.8%77.8%95.6%
    Granville House1110.057.5%74.3%90.5%
    Regent House10220.867.9%68.5%88.1%
    Library House9821.949.3%68.8%81.6%
    Coppull Medical1060.063.3%68.8%79.8%
    Chorley10624.958.4%69.2%71.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNChorleyAssetPCNChorley
    Care homes (catchment)16 (681 beds)n/aSchools (catchment)61n/a
    Children's centres58Places of worship5375
    Libraries44Primary schools (LA maintained)2239
    Primary academies45Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing recall

    Across 4,284 asthma patients (8.2% vs England 6.6%), 69.7% had an annual review (England 65.7%), leaving about 1,300 unreviewed, alongside 2,037 items prescribed per 1,000 aged 5-19 (England 1,488). For discussion: practices could run structured asthma recall combining inhaler technique checks and prescribing reviews, prioritising high-deprivation sites. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Lipid and diabetes prevention recall

    QRISK ≥ 20% lipid therapy is 60.4% (England 63.6%, ICB 61.4%), diabetes statin therapy (40+ without CVD) is 70.3% (England 73.2%), and non-frail diabetes HbA1c <= 58 mmol/mol is 55.6% (England 57.4%). For discussion: clinical pharmacists could run recall and titration reviews for high-risk CVD and diabetes patients. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    Learning disability and smoking offer audit

    Over 2023 to 2025, learning disability QOF prevalence fell 5.0% (385 patients, 0.7%; England +5.4%, ICB +5.0%) and smoking cessation offers fell 3.0 pp to 94.0% (England +0.1 pp). For discussion: practices could cross-check learning disability coding and embed routine smoking cessation prompts within annual review templates. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Proactive frailty and anticipatory care (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 preventive outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older hypertension blood pressure audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register safety netting audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Option 1 · Structured asthma review and prescribing recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Lipid and diabetes prevention recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · IFCC-HbA1c <= 58 mmol/mol in patients with diabetes without frailty (denominator incl. PCAs)NHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Option 3 · Learning disability and smoking offer audit (p12)Learning disability register · Learning disability: QOF prevalence · Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15